Ultragenyx Pharmaceutical Inc. (RARE) Posts Q1 Loss of 85c/Share
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Join SI Premium – FREE
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) reported Q1 EPS of ($0.85), $0.48 worse than the analyst estimate of ($0.37).
For earnings history and earnings-related data on Ultragenyx Pharmaceutical Inc. (RARE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Barnes & Noble Education (BNED) Tops Q1 EPS by 12c
- ABM Industries (ABM) Reports In-Line Q3 EPS; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
